Obligation to submit a variation application following PSUSA procedure
29.09.2025
more
News and Educations
Information to marketing authorisation holders regarding variation applications after referral for azithromycin-containing medicinal products for systemic use
18.09.2025
more
Newly approved medicinal products - August 2025
16.09.2025
more
Information to marketing authorisation holders regarding variation applications after referral for medicinal products which contain the active substance finasteride or dutasteride
11.09.2025
more
Newly approved medicinal products - July 2025
29.08.2025
more
Obligation to submit a variation application following PSUSA procedure
18.07.2025
more
Newly approved medicinal products - June 2025
15.07.2025
more
Newly approved medicinal products - May 2025
16.06.2025
more
The International Conference “PharmaConnect 2025” Held in Dubrovnik
22.05.2025
more
Newly approved medicinal products - April 2025
19.05.2025
more
